Homocysteine inhibits inactivation of factor Va by activated protein C. (Q31574546)

3 July 2017

title

Homocysteine inhibits inactivation of factor Va by activated protein C. (English)

1 reference

3 July 2017

1

Undas A

1 reference

3 July 2017

Williams EB

2

1 reference

3 July 2017

Butenas S

series ordinal

3

1 reference

3 July 2017

Orfeo T

series ordinal

4

1 reference

3 July 2017

Mann KG

series ordinal

5

1 reference

3 July 2017

language of work or name

English

0 references

publication date

16 November 2000

1 reference

Journal of Biological Chemistry

3 July 2017

published in

1 reference

3 July 2017

volume

276

1 reference

3 July 2017

issue

6

1 reference

3 July 2017

page(s)

4389-4397

1 reference

Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease

3 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

The oxidant stress of hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Complete cDNA and derived amino acid sequence of human factor V

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Isolation of functional human coagulation factor V by using a hybridoma antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

A simple method for the preparation of homogeneous phospholipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Determination of the disulfide bridges in factor Va light chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004124200

21 January 2018

Identifiers

DOI

10.1074/JBC.M004124200

1 reference

3 July 2017

1 reference